Literature DB >> 15725753

Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in São Paulo, Brazil.

Dercy José de Sa Filho1, Sabri Sanabani, Ricardo Sobhie Diaz, Patrícia Munerato, Adriana Brunstein, Erika Fusuma, Ester Cerdeira Sabino, Luiz Mario Janini.   

Abstract

Recombination is one of the major mechanisms contributing to human immunodeficiency virus type 1 (HIV-1) variability. Analysis of pol gene sequences of 215 HIV-1 samples from São Paulo, Brazil classified 189 sequences as subtype B (87.9%), 8 sequences as subtype F (3.7%), and 18 sequences (8.4%) as B/F recombinants. After the analysis of the pol gene, a subset of six recombinant samples composed of sequences with a related recombinant pol structure was selected for full-length genome analysis to identify a possible circulating recombinant form. According to full-length genome analysis, recombination was higher in gag, protease, reverse transcriptase, integrase, and vif. Identification of many distinct recombinant forms and the absence of an identifiable HIV-1 circulating recombinant form suggest that a high frequency of dual infections between HIV-1 subtypes B and F is occurring in São Paulo, Brazil.

Entities:  

Mesh:

Year:  2005        PMID: 15725753     DOI: 10.1089/aid.2005.21.145

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  HIV diversity, molecular epidemiology, and the role of recombination.

Authors:  Gustavo H Kijak; Francine E McCutchan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

2.  Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay.

Authors:  Gonzalo Bello; Paula C Aulicino; Dora Ruchansky; Monick L Guimarães; Cecilio Lopez-Galindez; Concha Casado; Hector Chiparelli; Carlos Rocco; Andrea Mangano; Luisa Sen; Mariza G Morgado
Journal:  Retrovirology       Date:  2010-03-22       Impact factor: 4.602

3.  Evidence of a novel RNA secondary structure in the coding region of HIV-1 pol gene.

Authors:  Qi Wang; Ian Barr; Feng Guo; Christopher Lee
Journal:  RNA       Date:  2008-10-30       Impact factor: 4.942

4.  Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil.

Authors:  Natalia Ristic; Jean Zukurov; Wagner Alkmim; Ricardo Sobhie Diaz; Luiz Mario Janini; Mario P S Chin
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

5.  BF integrase genes of HIV-1 circulating in São Paulo, Brazil, with a recurrent recombination region.

Authors:  Atila Iamarino; Fernando Lucas de Melo; Carla Torres Braconi; Paolo Marinho de Andrade Zanotto
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

6.  Analysis of HIV-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in São Paulo and Santos, Brazil.

Authors:  Edsel Renata De Morais Nunes; Jean Paulo Zukurov; Juliana Terzi Maricato; Maria Cecília Araripe Sucupira; Ricardo Sobhie Diaz; Luíz Mário Ramos Janini
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

7.  Distribution of human immunodeficiency virus type 1 subtypes in the State of Amazonas, Brazil, and subtype C identification.

Authors:  L K H Cunha; S Kashima; M F C Amarante; R Haddad; E S Rodrigues; K L T Silva; T A Lima; D B Castro; F C Brito; E G Almeida; D T Covas; A Malheiro
Journal:  Braz J Med Biol Res       Date:  2012-01-19       Impact factor: 2.590

8.  Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.

Authors:  Kledoaldo Lima; Élcio de Souza Leal; Ana Maria Salustiano Cavalcanti; Daniela Medeiros Salustiano; Luzidalva Barbosa de Medeiros; Sirleide Pereira da Silva; Heloísa Ramos Lacerda
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.